[go: up one dir, main page]

ES522529A0 - Un procedimiento para la preparacion de nuevos derivados de acidos alquiloxazolilaceticos. - Google Patents

Un procedimiento para la preparacion de nuevos derivados de acidos alquiloxazolilaceticos.

Info

Publication number
ES522529A0
ES522529A0 ES522529A ES522529A ES522529A0 ES 522529 A0 ES522529 A0 ES 522529A0 ES 522529 A ES522529 A ES 522529A ES 522529 A ES522529 A ES 522529A ES 522529 A0 ES522529 A0 ES 522529A0
Authority
ES
Spain
Prior art keywords
alquiloxazolilacetic
acids
procedure
preparation
new derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES522529A
Other languages
English (en)
Other versions
ES8407482A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of ES8407482A1 publication Critical patent/ES8407482A1/es
Publication of ES522529A0 publication Critical patent/ES522529A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES522529A 1982-05-19 1983-05-18 Un procedimiento para la preparacion de nuevos derivados de acidos alquiloxazolilaceticos. Granted ES522529A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57085282A JPS58201771A (ja) 1982-05-19 1982-05-19 アルキルオキサゾリル酢酸誘導体

Publications (2)

Publication Number Publication Date
ES8407482A1 ES8407482A1 (es) 1984-09-16
ES522529A0 true ES522529A0 (es) 1984-09-16

Family

ID=13854208

Family Applications (1)

Application Number Title Priority Date Filing Date
ES522529A Granted ES522529A0 (es) 1982-05-19 1983-05-18 Un procedimiento para la preparacion de nuevos derivados de acidos alquiloxazolilaceticos.

Country Status (4)

Country Link
US (1) US4535089A (es)
EP (1) EP0094612A3 (es)
JP (1) JPS58201771A (es)
ES (1) ES522529A0 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531608D0 (en) * 1985-12-23 1986-02-05 Beecham Group Plc Treatment
ES2245660T3 (es) * 1990-11-30 2006-01-16 Otsuka Pharmaceutical Co., Ltd. Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos.
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
CN103058946A (zh) * 2012-12-19 2013-04-24 浙江工业大学 一种2,5-二取代噁唑衍生物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3401120A (en) * 1965-10-23 1968-09-10 Gaf Corp Corrosion inhibitors
GB1139940A (en) * 1966-09-30 1969-01-15 Ici Ltd Oxazole derivatives
FI53314C (fi) * 1967-06-14 1978-04-10 Wyeth John & Brother Ltd Foerfarande foer framstaellning av farmaceutiskt anvaendbar 2-(fenyleller p-klorfenyl) oxazol-4-yl (aettiksyra -acetatsalt eller -acetamid)
AR208400A1 (es) * 1974-03-13 1976-12-27 Yoshitomi Pharmaceutical Un metodo para producir nuevos acidos 5-alcoxi-4-oxazolalcanoicos 2-substituidos y sus esteres
JPS57188587A (en) * 1981-05-15 1982-11-19 Tanabe Seiyaku Co Ltd Thienyloxazolylacetic acid derivative and its preparation

Also Published As

Publication number Publication date
JPH0357901B2 (es) 1991-09-03
ES8407482A1 (es) 1984-09-16
JPS58201771A (ja) 1983-11-24
EP0094612A2 (en) 1983-11-23
US4535089A (en) 1985-08-13
EP0094612A3 (en) 1985-01-23

Similar Documents

Publication Publication Date Title
ES521121A0 (es) Un procedimiento para la preparacion de derivados de benzotia-zolsulfonamida.
ES539625A0 (es) Un procedimiento para la preparacion de derivados de fenetano.
ES521635A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES520132A0 (es) Un procedimiento para la preparacion de derivados de 1-normon-2-ilo.
ES524446A0 (es) Un procedimiento para la preparacion de nuevos derivados.
ES536525A0 (es) Un procedimiento para la preparacion de derivados de fenotiazinas.
ES535953A0 (es) Un procedimiento para la preparacion de derivados 3-cefem-4-carboxilicos.
ES522678A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
ES524447A0 (es) Un procedimiento para la preparacion de nuevos derivados arilfenolicos.
ES538907A0 (es) Un procedimiento para la preparacion de derivados enol-eteres de oxicanis.
ES534509A0 (es) Un procedimiento para la preparacion de acidos fenilquinolin-carboxilicos.
ES524610A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES529846A0 (es) Un procedimiento para la preparacion de derivados benzoheterociclicos.
ES524317A0 (es) Un procedimiento para la preparacion de nuevos derivados de tienopirimidina.
ES508806A0 (es) Un procedimiento para la preparacion de derivados de acidos fenil-alcanoicos.
ES521192A0 (es) Un procedimiento para la preparacion de derivados de b-lactama.
ES533389A0 (es) Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida.
ES534642A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbaciclina.
ES529213A0 (es) Un procedimiento para la preparacion de derivados de isoquinuclidina.
ES522389A0 (es) Un procedimiento para la preparacion de nuevos derivados de penem-2-tiosustituidos.
ES534269A0 (es) Un procedimiento para la preparacion de nuevos derivados de difeniletanona.
ES526528A0 (es) Un procedimiento para la preparacion de derivados de difenilalquilenicos.
ES536687A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-azaciclos alquiltiopenen.
ES537359A0 (es) Un procedimiento para la preparacion de nuevos derivados de feniletanamina.
ES539066A0 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazolina.